Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke. 2010;41:2985 366. Brown DL, Chervin RD, Hickenbottom SL, Langa KM, Morgenstern LB. Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis. Stroke. 2005;36:1291 1293. doi: 367. Pack AI, Pien GW. Update on sleep and its disorders. Annu Rev Med. 368. Medeiros CA, de Bruin VM, Andrade GM, Coutinho WM, de Castro-Silva C, de Bruin PF. Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand. 2012;126:17 22. 369. Camilo MR, Sander HH, Eckeli AL, Fernandes RM, Dos Santos-Pontelli TE, Leite JP, Pontes-Neto OM. SOS score: an opti- mized score to screen acute stroke patients for obstructive sleep apnea. Sleep Med. 2014;15:1021 1024. doi: 10.1016/j.sleep.2014.03.026 370. Stahl SM, Yaggi HK, Taylor S, Qin L, Ivan CS, Austin C, Ferguson J, Radulescu R, Tobias L, Sico J, et al. Infarct location and sleep apnea: evaluating the potential association in acute ischemic stroke. Sleep Med. P rez-Ronchel J, Dur n-Cantolla J, de la Torre G, Gonz lez Marcos JR, de la Pe a M, et al. Early treatment of obstructive apnoea and stroke out- come: a randomised controlled trial. Eur Respir J. 2011;37:1128 1136. 372. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, et al; SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919 931. doi: 10.1056/NEJMoa1606599 373. C t R, Zhang Y, Hart RG, McClure LA, Anderson DC, Talbert RL, Benavente OR. ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology. 2014;82:382 374. Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Antiplatelet regimen for patients with breakthrough strokes while on aspirin: a sys- tematic review and meta-analysis. Stroke. 2017;48:2610 2613. doi: 375. John S, Katzan I. Recurrent stroke while on antiplatelet therapy. Neurol 376. Turan TN, Maidan L, Cotsonis G, Lynn MJ, Romano JG, Levine SR, ChimowitzMI;fortheWarfarin-AspirinSymptomaticIntracranialDisease Investigators. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009;40:505 377. Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, Hertzberg VS, Chaturvedi S, Levine SR, Stern BJ, Benesch CG, et al; Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 378. Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C, Pezzini A, Poli L, Padovani A, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibril- lation: effect of anticoagulation and its timing: the RAF Study. Stroke. 379. Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J; CADISS Trial Investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14:361 367. doi: 10.1016/ 380. Larsson SC, King A, Madigan J, Levi C, Norris JW, Markus HS. Prognosis of carotid dissecting aneurysms: results from CADISS and a systematic review. Neurology. 2017;88:646 652. doi: 381. Ahlhelm F, Benz RM, Ulmer S, Lyrer P, Stippich C, Engelter S. Endovascular treatment of cervical artery dissection: ten case reports and review of the literature. Interv Neurol. 2013;1:143 150. doi: 382. Kim JT, Heo SH, Park MS, Chang J, Choi KH, Cho KH. Use of anti- thrombotics after hemorrhagic transformation in acute ischemic stroke. PLoS One. 2014;9:e89798. doi: 10.1371/journal.pone.0089798 383. England TJ, Bath PM, Sare GM, Geeganage C, Moulin T, O Neill D, Woimant F, Christensen H, De Deyn P, Leys D, et al; TAIST Investigators. Asymptomatic hemorrhagic transformation of infarction and its relation- ship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke. 2010;41:2834 2839. 384. Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ce ka R, Lepor N, et al; GAUSS-3 Investigators. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA. 2016;315:1580 1590. doi: 10.1001/jama.2016.3608 385. Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ, Bruckert E, Jacobson TA, Kopecky SL, Baccara-Dinet MT, et al; ODYSSEY ALTERNATIVE Investigators. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechal- lenge arm: the ODYSSEY ALTERNATIVE randomized trial. J Clin 386. Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD Jr, DePalma SM, Minissian MB, Orringer CE, Smith SC, Jr. 2016 ACC ex- pert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardi- ovascular disease risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 387. Sanossian N, Saver JL, Liebeskind DS, Kim D, Razinia T, Ovbiagele B. Achieving target cholesterol goals after stroke: is in-hos- pital statin initiation the key? Arch Neurol. 2006;63:1081 1083. doi: 388. Hong KS, Lee JS. Statins in acute ischemic stroke: a systematic review. J Stroke. 2015;17:282 301. doi: 10.5853/jos.2015.17.3.282 389. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators. Fast Assessment of Stroke and Transient Ischaemic Attack to Prevent Early Recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961 969. doi: 390. Yoshimura S, Uchida K, Daimon T, Takashima R, Kimura K, Morimoto T; on behalf of the ASSORT Trial Investigator. Randomized controlled trial of early versus delayed statin therapy in patients with acute ischemic stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient). Stroke. 2017;48:3057 3063. doi: 391. Rigotti NA, Clair C, Munafo MR, Stead LF. Interventions for smok- ing cessation in hospitalised patients. Cochrane Database Syst Rev. 2012:CD001837. 392. Lee MJ, Park E, Kim HC, Lee HS, Cha MJ, Kim YD, Heo JH, Nam HS. Timely interventions can increase smoking cessation rate in men with ischemic stroke. J Korean Acad Nurs. 2016;46:610 617. doi: 393. Eisenberg MJ, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, et al; EVITA Investigators. Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome. Circulation. 2016;133:21 30. doi: 394. Schwartz J, Dreyer RP, Murugiah K, Ranasinghe I. Contemporary pre- hospital emergency medical services response times for suspected stroke in the United States. Prehosp Emerg Care. 2016;20:560 565. doi: 395. Boden-Albala B, Stillman J, Roberts ET, Quarles LW, Glymour MM, Chong J, Moats H, Torrico V, Parides MC. Comparison of acute stroke preparedness strategies to decrease emergency de- partment arrival time in a multiethnic cohort: the Stroke Warning Information and Faster Treatment Study. Stroke. 2015;46:1806 1812. 396. Morgenstern LB, Gonzales NR, Maddox KE, Brown DL, Karim AP, Espinosa N, Moy LA, Pary JK, Grotta JC, Lisabeth LD, et al.A random- ized, controlled trial to teach middle school children to recognize stroke and call 911: the Kids Identifying and Defeating Stroke project. Stroke. 397. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital 398. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. Paramedic identification of stroke: community validation of the Melbourne Ambulance Stroke Screen. Cerebrovasc Dis. 2005;20:28 33. doi: 399. Studnek JR,AsimosA, Dodds J, Swanson D.Assessing the validity of the CincinnatiPrehospitalStrokeScaleandtheMedicPrehospitalAssessment for Code Stroke in an urban emergency medical services agency. Prehosp Emerg Care. 2013;17:348 353. doi: 10.3109/10903127.2013.773113 400. Chenkin J, Gladstone DJ, Verbeek PR, Lindsay P, Fang J, Black SE, Morrison L. Predictive value of the Ontario prehospital stroke screening tool for the identification of patients with acute stroke. Prehosp Emerg 401. Asimos AW, Ward S, Brice JH, Rosamond WD, Goldstein LB, Studnek J. Out-of-hospital stroke screen accuracy in a state with an emergency med- ical services protocol for routing patients to acute stroke centers. Ann 402. Pickham D, Valdez A, Demeestere J, Lemmens R, Diaz L, Hopper S, de la Cuesta K, Rackover F, Miller K, Lansberg MG. Prognostic value of BEFAST vs. FAST to identify stroke in a prehospital setting. Prehosp Emerg Care. 2019;23:195 200. doi: 10.1080/10903127.2018.1490837 403. van Wijngaarden JD, Dirks M, Niessen LW, Huijsman R, Dippel DW. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke? QJM. 404. Jeng JS, Tang SC, Deng IC, Tsai LK,Yeh SJ,Yip PK. Stroke center char- acteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: a national survey of stroke centers in Taiwan. J Neurol Sci. 2009;281:24 27. doi: 10.1016/j.jns.2009.03.004 405. Douglas VC, Tong DC, Gillum LA, Zhao S, Brass LM, Dostal J, Johnston SC. Do the Brain Attack Coalition s criteria for stroke centers improve care for ischemic stroke? Neurology. 2005;64:422 427. doi: 406. Asimos AW, Norton HJ, Price MF, Cheek WM. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Emerg Med. 2004;11:361 370. doi: 10.1197/j.aem.2003.12.016 407. Sauser K, Levine DA, Nickles AV, Reeves MJ. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the con- tributions of door-to-imaging time and imaging-to-needle time. JAMA Dodick DW, Ward MP, Richemont PC, Brazdys K, et al; for the STRokE DOC AZ TIME Investigators. Stroke team remote evaluation using a dig- italobservationcamerainArizona:theinitialMayoClinicexperiencetrial. 409. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, Thomas RG, Lyden PD. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 410. Rai AT, Smith MS, Boo S, Tarabishy AR, Hobbs GR, Carpenter JS. The pit-crew model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project. J Neurointerv Surg. 2016;8:447 411. Muir KW, Ford GA, Messow CM, Ford I, Murray A, Clifton A, Brown MM, Madigan J, Lenthall R, Robertson F, et al; PISTE Investigators. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) ran- domised, controlled trial. J Neurol Neurosurg Psychiatry. 2017;88:38 412. Mocco J, Zaidat OO, von Kummer R, Yoo AJ, Gupta R, Lopes D, Frei D, Shownkeen H, Budzik R, Ajani ZA, et al; THERAPY Trial Investigators. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke. 2016;47:2331 2338. doi: 413. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893 903. doi: 414. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E; SYNTHESIS Expansion Investigators. Endovascular treat- ment for acute ischemic stroke. N Engl J Med. 2013;368:904 913. doi: Powers et al 2019 Guidelines for Management of AIS e415 415. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914 923. doi: 10.1056/NEJMoa1212793 416. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlu- sions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 417. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO; SWIFT Trialists. Solitaire flow restoration de- vice versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 418. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T; for the MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke. 419. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al. Intra-arterial prouro- kinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 420. Brazzelli M, Sandercock PA, Chappell FM, Celani MG, Righetti E, Arestis N,Wardlaw JM, Deeks JJ. Magnetic resonance imaging versus com- puted tomography for detection of acute vascular lesions in patients present- ing with stroke symptoms. Cochrane Database Syst Rev. 2009:CD007424. 421. Wardlaw JM, Carpenter T, Sakka E, Mair G, Cohen G, Shuler K, Palmer JM, Innes K, Sandercock PA. Imaging perfusion deficits, arterial patency and thrombolysis safety and efficacy in acute ischaemic stroke An observational study of the effect of advanced imaging methods in the Third International Stroke Trial (IST-3), a randomised controlled trial. In: Efficacy and Mechanism Evaluation, No. 1.1. Southampton, UK: NIHR Journals Library; 2014. 422. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, et al; EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a pla- cebo-controlled randomised trial. Lancet Neurol. 2008;7:299 309. doi: 423. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W; DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 424. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study: Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators. Stroke. 2000;31:811 816. doi: 425. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomized controlled trial: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282:2019 426. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, LarrueV, Bluhmki E, Davis S, Donnan G, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European- Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245 427. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, H xter G, Mahagne MH. Intravenous thromboly- sis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017 1025. 428. Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage fol- lowing intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis. 2012;34:106 114. doi: 429. Ali K, Warusevitane A, Lally F, Sim J, Sills S, Pountain S, Nevatte T, AllenM,RoffeC.TheStrokeOxygenPilotStudy:arandomizedcontrolled trial of the effects of routine oxygen supplementation early after acute stroke: effect on key outcomes at six months. PLoS One. 2014;8:e59274. 430. Singhal A, Partners SPOTRIAS Investigators. A phase IIB clinical trial of normobaric oxygen therapy (NBO) in acute ischemic stroke (AIS) (S02.001). Neurology. 2013;80(suppl):S02.001. 431. Roffe C, Ali K, Warusevitane A, Sills S, Pountain S, Allen M, Hodsoll J, Lally F, Jones P, Crome P. The SOS pilot study: a RCT of rou- tine oxygen supplementation early after acute stroke: effect on recovery of neurological function at one week. PLoS One. 2011;6:e19113. doi: 432. Roffe C, Sills S, Pountain SJ, Allen M. A randomized controlled trial of the effect of fixed-dose routine nocturnal oxygen supplementation on ox- ygen saturation in patients with acute stroke. J Stroke Cerebrovasc Dis. 433. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG. A pilot study of nor- mobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797 434. R nning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 435. AdelmanEE,ScottPA,SkolarusLE,FoxAK,FrederiksenSM,MeurerWJ. Protocol deviations before and after treatment with intravenous tissue plasminogen activator in community hospitals. J Stroke Cerebrovasc Dis. 436. Kodankandath TV, Shaji J, Kohn N, Arora R, Salamon E, Libman RB, Katz JM. Poor hypertension control and longer trans- port times are associated with worse outcome in drip-and-ship stroke patients. J Stroke Cerebrovasc Dis. 2016;25:1887 1890. doi: RawalPV,KapoorN,AlviM,SissonA,AlexandrovAW,etal.Safetyofpro- tocol violations in acute stroke tPA administration. J Stroke Cerebrovasc 438. Kellert L, Rocco A, Sykora M, Hacke W, Ringleb PA. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage. Stroke. 2011;42:1702 1706. doi: 439. Karaszewski B, Thomas RG, Dennis MS, Wardlaw JM. Temporal profile of body temperature in acute ischemic stroke: relation to stroke severity 440. den Hertog HM, van derWorp HB, van Gemert HM,AlgraA, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW. An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study. J Neurol. 2011;258:302 307. doi: 10.1007/s00415-010-5756-4 441. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, K ppers-Tiedt L, Schneider D, Schmutzhard E. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. 442. den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW; PAIS Investigators. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicen- tre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 443. Horn CM, Sun CH, Nogueira RG, Patel VN, Krishnan A, Glenn BA, Belagaje SR, Thomas TT,AndersonAM, Frankel MR, et al. Endovascular Reperfusion and Cooling in Cerebral Acute Ischemia (ReCCLAIM I). J Neurointerv Surg. 2014;6:91 95. doi: 10.1136/neurintsurg-2013-010656 444. Su Y, Fan L, Zhang Y, Zhang Y, Ye H, Gao D, Chen W, Liu G. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction. Stroke. 2016;47:457 463. doi: hypothermia after recanalization in patients with acute ischemic stroke. 446. Ovesen C, Brizzi M, Pott FC, Thorsen-Meyer HC, Karlsson T, Ersson A, Christensen H, Norrlin A, Meden P, Krieger DW, et al. Feasibility of endovascular and surface cooling strategies in acute stroke. Acta Neurol 447. Li W, Lin L, Zhang M, Wu Y, Liu C, Li X, Huang S, Liang C, Wang Y, Chen J, et al. Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients. Stroke. 2016;47:2649 448. Wada T,Yasunaga H, Horiguchi H, Fushimi K, Matsubara T, Nakajima S, Yahagi N. Ozagrel for patients with noncardioembolic ischemic stroke: a propensity score-matched analysis. J Stroke Cerebrovasc Dis. 449. Mori E, Minematsu K, Nakagawara J, HasegawaY, Nagahiro S, OkadaY, Truelsen T, Lindsten A, Ogawa A,Yamaguchi T; on behalf of the DIAS-J Investigators. Safety and tolerability of desmoteplase within 3 to 9 hours after symptoms onset in Japanese patients with ischemic stroke. Stroke. 450. Multicenter Acute Stroke Trial Europe Study Group, Hommel M, Cornu C, Boutitie F, Boissel JP. Thrombolytic therapy with streptoki- nase in acute ischemic stroke. N Engl J Med. 1996;335:145 150. doi: 451. Multicentre Acute Stroke Trial Italy (MAST-I) Group. Randomised con- trolled trial of streptokinase, aspirin, and combination of both in treat- ment of acute ischaemic stroke. Lancet. 1995;346:1509 1514. 452. Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Davalos A, Bonafe A, Jahan R, Fischer U, Gralla J, et al. Combined in- travenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke: a pooled analysis of the SWIFT and STAR studies. JAMA Neurol. 2017;74:268 274. doi: 10.1001/jamaneurol.2016.5374 453. Grech R, Pullicino R, Thornton J, Downer J. An efficacy and safety com- parison between different stentriever designs in acute ischaemic stroke: a systematic review and meta-analysis. Clin Radiol. 2016;71:48 57. doi: 454. Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016;353:i1754. doi: 455. Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Stent retrievers for the treatment of acute ischemic stroke: a systematic review and meta-analysis of randomized clinical trials. JAMA Neurol. 456. Badhiwala JH, Nassiri F,Alhazzani W, Selim MH, Farrokhyar F, Spears J, Kulkarni AV, Singh S, Alqahtani A, Rochwerg B, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. 457. Chen CJ, Ding D, Starke RM, Mehndiratta P, Crowley RW, Liu KC, Southerland AM, Worrall BB. Endovascular vs medical man- agement of acute ischemic stroke. Neurology. 2015;85:1980 1990. doi: 458. Elgendy IY, Kumbhani DJ, Mahmoud A, Bhatt DL, Bavry AA. Mechanical Thrombectomy for acute ischemic stroke: a meta-analysis of randomized trials. J Am Coll Cardiol. 2015;66:2498 2505. doi: 459. Fargen KM, Neal D, Fiorella DJ, Turk AS, Froehler M, Mocco J. A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke. J Neurointerv Surg. 460. Kumar G, Shahripour RB, Alexandrov AV. Recanalization of acute bas- ilar artery occlusion improves outcomes: a meta-analysis. J Neurointerv 461. Marmagkiolis K, Hakeem A, Cilingiroglu M, Gundogdu B, Iliescu C, Tsitlakidou D, Katramados A. Safety and efficacy of stent retrievers for the management of acute ischemic stroke: comprehensive review and meta-analysis. JACC Cardiovasc Interv. 2015;8:1758 1765. doi: 462. Yarbrough CK, Ong CJ, Beyer AB, Lipsey K, Derdeyn CP. Endovascular thrombectomy for anterior circulation stroke: systematic review and meta-analysis. Stroke. 2015;46:3177 3183. doi: 10.1161/STROKEAHA. 463. Almekhlafi MA, Menon BK, Freiheit EA, Demchuk AM, Goyal M. A meta-analysis of observational intra-arterial stroke therapy studies using the Merci device, Penumbra system, and retrievable stents. AJNR Am J 464. Fields JD, Khatri P, Nesbit GM, Liu KC, Barnwell SL, Lutsep HL, Clark WM, Lansberg MG. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle ce- rebral artery occlusion. J Neurointerv Surg. 2011;3:151 155. doi: 465. L whagen Hend n P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, Dunker D, Schnabel K, Wikholm G, Hellstr m M, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (Anesthesia During Stroke). 466. BrinjikjiW,MuradMH,RabinsteinAA,CloftHJ,LanzinoG,KallmesDF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36:525 529. doi: 10.3174/ajnr.A4159 467. Wada T, Yasunaga H, Horiguchi H, Matsubara T, Fushimi K, Nakajima S, Yahagi N. Outcomes of argatroban treatment in patients with atherothrombotic stroke: observational nationwide study in Japan. 468. Sandercock PA, Counsell C, Kamal AK. Anticoagulants for acute isch- aemic stroke. Cochrane Database Syst Rev. 2008:CD000024. 469. Wang Q, Chen C, Chen XY, Han JH, Soo Y, Leung TW, Mok V, Wong KS. Low-molecular-weight heparin and early neurologic deteri- oration in acute stroke caused by large artery occlusive disease. Arch 470. Wang QS, Chen C, Chen XY, Han JH, SooY, LeungTW, MokV,Wong KS. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study. 471. Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, Diener HC, Lees KR; VISTA Collaborators. Association of improved outcome in acute ischaemic stroke patients with atrial fibrilla- tion who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol. 2015;22:1048 1055. doi: 10.1111/ene.12577 472. Jensen J, Salottolo K, Frei D, Loy D, McCarthy K, Wagner J, Whaley M, Bellon R, Bar-Or D. Comprehensive analysis of intra-arterial treatment for acute ischemic stroke due to cervical artery dissection. J Neurointerv 473. Deleted in proof. 474. Seedat J, Penn C. Implementing oral care to reduce aspiration pneu- monia amongst patients with dysphagia in a South African setting. S Afr J Commun Disord. 2016;63. doi: 10.4102/sajcd.v63i1.102 475. Geeganage CM, Sprigg N, Bath MW, Bath PM. Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-doseanticoagulationinrecentischemicstroke:asystematicreviewand meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis. 476. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Venous thromboembolism prophylaxis in hospitalized patients: a clinical prac- tice guideline from the American College of Physicians. Ann Intern Med. 477. Wang SB, Wang YY, Zhang QE, Wu SL, Ng CH, Ungvari GS, Chen L, Wang CX, Jia FJ, XiangYT. Cognitive behavioral therapy for post-stroke depression: a meta-analysis. J Affect Disord. 2018;235:589 596. doi: 478. Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Chen W, Chen L, Yang MX. Efficacy, acceptability, and tolerability of antide- pressant treatments for patients with post-stroke depression: a network meta-analysis. Braz J Med Biol Res. 2018;51:e7218. doi: 10.1590/ 479. Cui M, Huang CY, Wang F. Efficacy and safety of citalopram for the treat- ment of poststroke depression: a meta-analysis. J Stroke Cerebrovasc Dis. 480. Deng L, Qiu S, Yang Y, Wang L, Li Y, Lin J, Wei Q, Yang L, Wang D, Liu M. Efficacy and tolerability of pharmacotherapy for post-stroke de- pression: a network meta-analysis. Oncotarget. 2018;9:23718 23728. 481. Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, Zhao C. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ Open. 2017;7:e016499. doi: 482. Deng L, Sun X, Qiu S, Xiong Y, Li Y, Wang L, Wei Q, Wang D, Liu M. Interventions for management of post-stroke depression: a bayesian network meta-analysis of 23 randomized controlled trials. Sci Rep. 483. Shen X, Liu M, Cheng Y, Jia C, Pan X, Gou Q, Liu X, Cao H, Zhang L. Repetitive transcranial magnetic stimulation for the treatment of post- stroke depression: a systematic review and meta-analysis of random- ized controlled clinical trials. J Affect Disord. 2017;211:65 74. doi: 484. Xu XM, Zou DZ, Shen LY, Liu Y, Zhou XY, Pu JC, Dong MX, Wei YD. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression. Medicine (Baltimore). 2016;95:e5349. doi: Powers et al 2019 Guidelines for Management of AIS e417 485. Tan S, Huang X, Ding L, Hong H. Efficacy and safety of citalopram in treating post-stroke depression: a meta-analysis. Eur Neurol. 486. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008:CD003437. 487. Herisson F, Godard S, Volteau C, Le Blanc E, Guillon B, Gaudron M; SEVEL Study Group. Early Sitting in Ischemic Stroke Patients (SEVEL): a randomized controlled trial. PLoS One. 2016;11:e0149466. doi: 488. Morreale M, Marchione P, Pili A, Lauta A, Castiglia SF, Spallone A, Pierelli F, Giacomini P. Early versus delayed rehabilitation treatment in hemiplegic patients with ischemic stroke: proprioceptive or cognitive approach? Eur J Phys Rehabil Med. 2016;52:81 89. 489. Meenan RT, Saha S, Chou R, Swarztrauber K, Pyle Krages K, O Keeffe-RosettiMC,McDonaghM,ChanBK,HornbrookMC,HelfandM. Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis 490. McNamara RL, Lima JA, Whelton PK, Powe NR. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis. Ann Intern Med. 491. Shariat A, Yaghoubi E, Farazdaghi M, Aghasadeghi K, Borhani Haghighi A. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci. 2013;18:94 98. 492. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625 2631. 493. Ma Y, Li D, Bai F, Qin F, Li J, Li Y, Liu N, Xie H, Zhou S, Liu Q. Patent foramen ovale closure or medical therapy for secondary pre- vention of cryptogenic stroke: an update meta-analysis of random- ized controlled trials. Medicine (Baltimore). 2018;97:e11965. doi: 494. Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018;107:745 755. doi: 495. Fiorelli EM, Carandini T, Gagliardi D, Bozzano V, Bonzi M, Tobaldini E, Comi GP, Scarpini EA, Montano N, Solbiati M. Secondary prevention of cryptogenic stroke in patients with patent foramen ovale: a systematic review and meta-analysis. Intern Emerg Med. 2018;13:1287 1303. doi: 496. Xu HB, Zhang H, Qin Y, Xue F, Xiong G, Yang L, Bai H, Wu J. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis. J Neurol Sci. 2018;390:139 149. doi: 497. Tsivgoulis G, Katsanos AH, Mavridis D, Frogoudaki A, Vrettou AR, Ikonomidis I, Parissis J, Deftereos S, Karapanayiotides T, Palaiodimou L, et al. Percutaneous patent foramen ovale closure for secondary stroke prevention: network meta-analysis. Neurology. 2018;91:e8 e18. doi: 498. Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, Demir O, Williams L, Iglesias JF, Sutaria N, et al. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of ran- domized controlled trials. Eur Heart J. 2018;39:1638 1649. doi: 499. Riaz H, Khan MS, Schenone AL, Waheed AA, Khan AR, Krasuski RA. Transcatheter closure of patent foramen ovale following cryptogenic stroke: an updated meta-analysis of randomized controlled trials. Am Heart J. 2018;199:44 50. doi: 10.1016/j.ahj.2018.01.008 500. Shah R, Nayyar M, Jovin IS, RashidA, Bondy BR, Fan TM, Flaherty MP, Rao SV. Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta- analysis. Ann Intern Med. 2018;168:335 342. doi: 10.7326/M17-2679 501. De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C. Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern 502. Zhang XL, Kang LN, Wang L, Xu B. Percutaneous closure versus medical therapy for stroke with patent foramen ovale: a systematic re- view and meta-analysis. BMC Cardiovasc Disord. 2018;18:45. doi: 503. Palaiodimos L, Kokkinidis DG, Faillace RT, Foley TR, Dangas GD, Price MJ, Mastoris I. Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018;19(pt B):852 858. doi: 504. Ando T, Holmes AA, Pahuja M, Javed A, Briasoulis A, Telila T, Takagi H, Schreiber T, Afonso L, Grines CL, et al. Meta-analysis com- paring patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke. Am J Cardiol. 2018;121:649 655. doi: 505. Lattanzi S, Brigo F, Cagnetti C, Di Napoli M, Silvestrini M. Patent fo- ramen ovale and cryptogenic stroke or transient ischemic attack: to close or not to close? A systematic review and meta-analysis. Cerebrovasc Dis. 506. Higgins JP, Altman DG, G tzsche PC, J ni P, Moher D, Oxman AD, SavovicJ,SchulzKF,WeeksL,SterneJA;CochraneBiasMethodsGroup; Cochrane Statistical Methods Group. The Cochrane Collaboration s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. 507. Johansson E, Cuadrado-Godia E, Hayden D, Bjellerup J, OisA, Roquer J, Wester P, Kelly PJ. Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: a pooled analysis. Neurology. 2016;86:498 508. Bazan HA, Zea N, Jennings B, Smith TA, Vidal G, Sternbergh WC 3rd. Urgent carotid intervention is safe after thrombolysis for minor to mod- erate acute ischemic stroke. J Vasc Surg. 2015;62:1529 1538. doi: 509. Chisci E, Pigozzi C, Troisi N, Tramacere L, Zaccara G, Cincotta M, ErcoliniL,MichelagnoliS.Thirty-dayneurologicimprovementassociated withearlyversusdelayedcarotidendarterectomyinsymptomaticpatients. Ann Vasc Surg. 2015;29:435 442. doi: 10.1016/j.avsg.2014.08.028 510. Devlin TG, Phade SV, Hutson RK, Fugate MW, Major GR 2nd, Albers GW, Sirelkhatim AA, Sapkota BL, Quartfordt SD, Baxter BW. Computed tomography perfusion imaging in the selection of acute stroke patients to undergo emergent carotid endarterectomy. Ann Vasc Surg. 511. Steglich-Arnholm H, Holtmannsp tter M, Kondziella D, Wagner A, StavngaardT,CronqvistME,HansenK,H jgaardJ,TaudorfS,KriegerDW. Thrombectomy assisted by carotid stenting in acute ischemic stroke management: benefits and harms. J Neurol. 2015;262:2668 2675. doi: 512. Ferrero E, Ferri M, Viazzo A, Labate C, Berardi G, Pecchio A, Piazza S, Ripepi M, Nessi F. A retrospective study on early carotid endarterectomy within 48 hours after transient ischemic attack and stroke in evolution. Ann Vasc Surg. 2014;28:227 238. doi: 10.1016/j.avsg.2013.02.015 513. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, et al; CHANCE Investigators. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015;85:1154 514. Jung JM, Kang DW, Yu KH, Koo JS, Lee JH, Park JM, Hong KS, Cho YJ, Kim JS, Kwon SU; TOSS-2 Investigators. Predictors of recur- rent stroke in patients with symptomatic intracranial arterial stenosis. 515. Coutts SB, Wein TH, Lindsay MP, Buck B, Cote R, Ellis P, Foley N, Hill MD, Jaspers S, Jin AY, et al; Heart, and Stroke Foundation Canada Canadian Stroke Best Practices Advisory Committee. Canadian stroke best practice recommendations: secondary prevention of stroke guide- lines, update 2014. Int J Stroke. 2015;10:282 291. doi: 10.1111/ijs.12439 516. Lanza G, Ricci S, Setacci C, Castelli P, Novalil C, Pratesi C, Speziale F, Cremonesi A, Morlacchi E, Lanza J, et al. An update on Italian Stroke Organization guidelines on carotid endarterectomy and stenting. Int J 517. Kakisis JD, Avgerinos ED, Antonopoulos CN, Giannakopoulos TG, Moulakakis K, Liapis CD. The European Society for Vascular Surgery guidelines for carotid intervention: an updated independent assessment and literature review. Eur J Vasc Endovasc Surg. 2012;44:238 243. 518. Paraskevas KI, Mikhailidis DP, Veith FJ. Comparison of the five 2011 guidelines for the treatment of carotid stenosis. J Vasc Surg. 2012;55:1504 1508. 519. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, et al. 2011 ASA/ACCF/ AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and verte- bral artery disease: executive summary: a report of theAmerican College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for CardiovascularAngiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery [published correction appears in Circulation. 2011;124:e145]. Circulation. 520. Ricotta JJ, Aburahma A, Ascher E, Eskandari M, Faries P, Lal BK; Society for Vascular Surgery. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg. 2011;54:832 836. doi: 10.1016/j.jvs.2011.07.004 521. Carotid Stenting Guidelines Committee: an Intercollegiate Committee of the RACP, RACS AND RANZCR. Guidelines for patient selection and performance of carotid artery stenting. Intern Med J. 2011;41:344 347. 522. Sheffet AJ, Roubin G, Howard G, Howard V, Moore W, Meschia JF, Hobson RW 2nd, Brott TG. Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke. 2010;5:40 46. 523. Latchaw RE,Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, Hobson R, Kidwell CS, Koroshetz WJ, Mathews V, et al; on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, and the Interdisciplinary Council on Peripheral Vascular Disease. Recommendations for imaging of acute is- chemic stroke: a scientific statement from theAmerican HeartAssociation. 524. European Stroke Organisation Executive Committee and ESO Writing Committee. Guidelines for management of ischaemic stroke and tran- sient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457 507. doi: HerholzK,MarkusHS,Mart nez-VilaE,NiederkornK,etal;EFNS.EFNS guidelineonneuroimaginginacutestroke:reportofanEFNStaskforce.Eur J Neurol. 2006;13:1271 1283. doi: 10.1111/j.1468-1331.2006.01507.x 526. Limone BL, Baker WL, Mearns ES, White CM, Kluger J, Coleman CI. Common flaws exist in published cost-effectiveness models of phar- macologic stroke prevention in atrial fibrillation. J Clin Epidemiol. 527. HigginsP,MacFarlanePW,DawsonJ,McInnesGT,LanghorneP,LeesKR. Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke. 2013;44:2525 528. Miles JA, Garber L, Ghosh S, Spevack DM. Association of transthoracic echocardiography findings and long-term outcomes in patients undergo- ing workup of stroke. J Stroke Cerebrovasc Dis. 2018;27:2943 2950. 529. Haeusler KG, Wollboldt C, Bentheim LZ, Herm J, J ger S, Kunze C, Eberle HC, Deluigi CC, Bruder O, Malsch C, et al. Feasibility and diag- nostic value of cardiovascular magnetic resonance imaging after acute is- chemic stroke of undetermined origin. Stroke. 2017;48:1241 1247. doi: 530. Katsanos AH, Giannopoulos S, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Zompola C, Vadikolias K, Boviatsis E, Parissis J, et al. The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis. Eur J Neurol. 535. GaudronM,BonnaudI,RosA,PatatF,deToffolB,GiraudeauB,DebiaisS. Diagnostic and therapeutic value of echocardiography during the acute phase of ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:2105 2109. 532. Kim SJ, Choe YH, Park SJ, Kim GM, Chung CS, Lee KH, Bang OY. Routine cardiac evaluation in patients with ischaemic stroke and absence of known atrial fibrillation or coronary heart disease: transthoracic ech- ocardiography vs. multidetector cardiac computed tomography. Eur J 533. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35 41. doi: 534. Galougahi KK, Stewart T, Choong CY, Storey CE, Yates M, Tofler GH. The utility of transoesophageal echocardiography to determine manage- ment in suspected embolic stroke. Intern Med J. 2010;40:813 818. doi: 535. Deleted in proof. 536. de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER, Bollen EL, Bax JJ. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37:2531 537. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke. 2006;37:859 864. doi: 538. Abreu TT, Mateus S, Correia J. Therapy implications of transtho- racic echocardiography in acute ischemic stroke patients. Stroke. 539. Vitebskiy S, Fox K, Hoit BD. Routine transesophageal echocardiography fortheevaluationofcerebralemboliinelderlypatients.Echocardiography. 540. Kim JT, Park MS, Choi KH, Cho KH, Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, et al. Different antiplatelet strategies in patients with new ischemic stroke while taking aspirin. Stroke. 2016;47:128 134. 541. Lee M, Wu YL, Saver JL, Lee HC, Lee JD, Chang KC, Wu CY, Lee TH, Wang HH, Rao NM, et al. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study. BMJ Open. 2014;4:e006672. doi: 10.1136/bmjopen-2014-006672 542. Aronow HD, Novaro GM, Lauer MS, Brennan DM, Lincoff AM, Topol EJ, Kereiakes DJ, Nissen SE. In-hospital initiation of lipid-low- ering therapy after coronary intervention as a predictor of long-term uti- lization: a propensity analysis. Arch Intern Med. 2003;163:2576 2582. 543. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined phar- macotherapy and behavioural interventions for smoking ces- sation. Cochrane Database Syst Rev. 2016;3:CD008286. doi: 544. Stead LF, Koilpillai P, Lancaster T. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2015:CD009670. doi: 10.1002/14651858.CD009670.pub3